are side effects worse on semaglutide or tirzepatide vs Tirzepatide: Which Leads to More Weight Loss? Is Tirzepatide Better Than Semaglutide?

North America Accounts for the Largest Share of the Market In terms of the key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Latin America

A subset of 532 participants with BMI 35 at baseline who tolerated their assigned dose continued into an extension out to 104 weeks

Bartfield says some data suggests its a good approach for people who have a BMI of 50 or higher and/or multiple weight-related conditions, like type 2 diabetes and sleep apnea, for example

Combining stimulant and non-stimulant appetite suppressants without robust clinical data creates uncertainty about cumulative cardiac load, arrhythmia risk, and long-term tolerability

Semaglutide protects the heart even in people without diabetes